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Summary
Stargardt disease (STGD) is the most common he-
reditary macular dystrophy and is characterized by de-
creased central vision, atrophy of the macula and un-
derlying retinal-pigment epithelium, and frequent pres-
ence of prominent flecks in the posterior pole of the
retina. STGD is most commonly inherited as an auto-
somal recessive trait, but many families have been de-
scribed in which features of the disease are transmitted
in an autosomal dominant manner. A recessive locus has
been identified on chromosome 1p (STGD1), and dom-
inant loci have been mapped to both chromosome 13q
(STGD2) and chromosome 6q (STGD3). In this study,
we describe a kindred with an autosomal dominant Star-
gardt-like phenotype. A genomewide search demon-
strated linkage to a locus on chromosome 4p, with a
maximum LOD score of 5.12 at a recombination frac-
tion of .00, for marker D4S403. Analysis of extended
haplotypes localized the disease gene to an ∼12-cM in-
terval between loci D4S1582 and D4S2397. Therefore,
this kindred establishes a new dominant Stargardt-like
locus, STGD4.
Introduction
Age-related macular degeneration (AMD) represents a
heterogeneous group of retinal disorders and is the most
common cause of irreversible blindness among elderly
individuals in the United States (Bressler et al. 1988).
Stargardt disease (STGD) shows some similarities to
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AMD. It is the most common hereditary macular dys-
trophy, with a prevalence of ∼1/10,000. Clinically,
STGD is characterized by decreased central vision during
the first several decades of life, bilateral “bull’s-eye” at-
rophy or a “beaten-bronze” appearance of the macula
and underlying retinal-pigment epithelium, and frequent
presence of prominent yellow “flavimaculatus flecks” in
the posterior pole of the retina (Stargardt 1909; Hadden
and Gass 1976; Noble and Carr 1979). Fluorescein an-
giography reveals a virtually pathognomonic “dark cho-
roid” pattern (Fish et al. 1981). Electroretinography is
normal early in the course of the disease but often shows
mild to moderate abnormalities in late stages (Fishman
1976).
Classically, STGD is inherited in an autosomal reces-
sive manner. A recessive locus has been mapped to chro-
mosome 1p (STGD1 [MIM 248200]), and the corre-
sponding gene on chromosome 1p has been cloned
(Kaplan et al. 1993; Allikmets et al. 1997b). This gene
encodes a retina-specific transmembrane protein, ABCR,
which belongs to the ATP-binding cassette family of
membrane transporters. It is of particular interest that
mutations in the ABCR gene have been reported in a
subset of patients with AMD (Allikmets et al. 1997a),
although it should be noted that the interpretation of
this finding is controversial (Dryja et al. 1998; Klaver et
al. 1998; Stone et al. 1998). In addition to the more
common recessive pattern, many families have been de-
scribed in which features of STGD are transmitted in an
autosomal dominant manner (Cibis et al. 1980; Lopez
et al. 1990; Mansour 1992; Stone et al. 1994; Zhang et
al. 1994). Dominant loci have been mapped to chro-
mosome 13q (STGD2 [MIM 153900]) and to chro-
mosome 6q (STGD3 [MIM 600110]) (Stone et al. 1994;
Zhang et al. 1994).
In this report, we describe a kindred affected with an
autosomal dominant form of STGD mapping to a new
disease locus, on chromosome 4. In accordance with the
guidelines of the HUGO Nomenclature Committee, the
gene causing this disorder has been designated
“STGD4.” Linkage was established with a two-point
maximum LOD score (Zmax) of 5.12 at , betweenv  .00
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Figure 1 Fundus photograph and fluorescein angiogram from
right eye of patient III-13, a 33-year-old woman with decreased vision
since age 15 years. Visual acuity was 20/400 in the right eye and 20/
50 in the left eye. A, Fundus photograph showing bull’s-eye macular
atrophy. B, Fluorescein angiogram revealing dark-choroid pattern, as
well as central retinal epithelial atrophy surrounded by numerous hy-
perfluorescent spots consistent with flavimaculatus flecks.
the disease and marker locus D4S403, and a 10-cM crit-
ical region between marker loci D4S1582 and D4S2397
was identified by analysis of extended haplotypes.
Subjects and Methods
Subjects
Informed consent was obtained from all participants,
in accordance with the guidelines established by the
Johns Hopkins University School of Medicine, Balti-
more. Twenty-six members of a three-generation, non-
consanguineous Caribbean family were identified for
study. A complete ophthalmic history was obtained, and
an examination was performed on each subject. Indi-
viduals were considered to be affected on the basis of
the presence of decreased visual acuity and bull’s-eye or
similar macular atrophy. Fluorescein angiography was
done in four affected subjects, and two affected subjects
underwent electroretinographic testing.
Genomic DNA Isolation and Genotype Analysis
Blood was collected from family members by veni-
puncture, and genomic DNA was isolated with the
QIAamp blood kit (Qiagen), according to the manu-
facturer’s instructions. All DNA samples were analyzed
with polymorphic short tandem repeat (STR) markers
spanning 22 autosomes, with a step of ∼24.2 cM (Re-
search Genetics). PCR was performed according to the
manufacturer’s protocol (Research Genetics). In most
cases, multiplex PCRwas used. After amplification, PCR
fragments were separated on a denaturing 6% poly-
acrylamide gel, and bands were visualized by exposure
of the dry gel to x-ray film (Kodak).
Linkage Analysis
Two-point and multipoint linkage analysis was con-
ducted with the LINKAGE (version 5.1) package (La-
throp et al. 1985). Linkage analysis was done under
conditions of no sex differences in recombination, com-
plete disease penetrance, and disease-gene frequency of
1/10,000. Allele frequencies for the markers used were
determined by the genotyping of 40 additional chro-
mosomes. The reference genetic map used for linkage
analysis was obtained from the Human Gene Map (Dib
et al. 1996).
Haplotype Analysis
Extended haplotypes of the individuals were con-
structed according to the order of STR markers in the
Ge´ne´thon genetic linkage map (Dib et al. 1996). Re-
construction of haplotypes was done, whenever possible,
for individuals whose DNA samples were not available.
Results
Clinical Examination
Twelve of the 18 individuals at risk for inheriting the
disease were found to be affected, on the basis of the
presence of decreased visual acuity and macular atrophy
(fig. 1A). Fluorescein angiography was done in four af-
fected subjects, all of whom demonstrated the charac-
teristic dark-choroid pattern of STGD. Three of the four
fluorescein angiograms revealed typical STGD flavima-
culatus flecks (fig. 1B). In addition, two affected subjects
underwent electroretinographic testing. One of these in-
dividuals had a normal rod-photoreceptor response and
a mildly decreased cone-photoreceptor response, and the
other had a very mildly reduced rod response and a
mildly reduced cone response (authors’ unpublished
Figure 2 Autosomal dominant Stargardt-like–disease pedigree. Boxes indicate the disease haplotypes. Squares denote males; circles denote females; blackened symbols denote affected individuals;
unblackened symbols denote unaffected individuals; a diagonal slash through a symbol denotes that the individual is deceased; dashes (-) denote that data were not available.
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Table 1
Two-Point LOD Scores between Dominant Stargardt-Like Disease and DNA Markers
MARKER
LOD SCORE AT v 
.00 .01 .06 .11 .16 .21 .26 .31 .36 .41
D4S3007  -2.12 .09 .69 .94 1.03 1.01 .91 .75 .53
D4S1582  -.13 1.28 1.60 1.66 1.60 1.46 1.26 1.00 .69
D4S2639 4.21 4.15 3.81 3.45 3.08 2.68 2.26 1.81 1.35 .87
D4S2944 .55 .51 .50 .46 .43 .38 .32 .26 .19 .12
D4S1602 4.82 4.74 4.36 3.96 3.53 3.08 2.60 2.09 1.56 1.012
D4S403 5.12 5.04 4.63 4.20 3.76 3.28 2.77 2.23 1.67 1.08
D4S1601 4.82 4.74 4.36 3.96 3.53 3.08 2.60 2.09 1.56 1.01
D4S2397  .16 1.42 1.64 1.65 1.56 1.39 1.18 .93 .63
Figure 3 Graph of multipoint LOD score, with genetic distance
(in morgans) plotted versus the LOD score. The location of D4S3007
marker is considered to be at map position 0. The dotted line is drawn
at , to show a support interval for the maximum-likeli-y  Z  3max
hood estimate.
data). A pedigree was constructed, with affected mem-
bers of both sexes in each generation (fig. 2). Taken
together, these data are consistent with autosomal dom-
inant transmission of a Stargardt-like disease.
Genetic-Linkage Studies
Polymorphic STR markers previously known to be
linked to STGD, cone dystrophy (COD), and cone-rod
dystrophy (CORD) were examined first. The analyzed
loci included STGD2 on 13q34 (Zhang et al. 1994),
STGD3 on 6q (Stone et al. 1994), COD3 (MIM602093)
on 6p21 (Payne et al. 1998), CORD2 (MIM 120970)
on 19q13 (Evans et al. 1994; Freund et al. 1997; Swain
et al. 1997), CORD5 (MIM 600977) on 17p (Small et
al. 1996), and CORD6 (MIM 601777) on chromosome
17p12-p13 (Kelsell et al. 1997). No significant linkage
was found to any of these loci.
A genomewide scan with 147 STR markers was per-
formed, and linkage was found after 59% of the genome
was excluded as a location of the disease gene. Two-
point linkage analysis revealed a locus on chromosome
4, with at , for marker D4S403 (ta-Z  5.12 v  .00max
ble 1). Linkage analysis was refined with 14 additional
STR markers spanning a 32-cM region centered around
marker D4S403. The LOD scores for loci D4S2639,
D4S1602, and D4S1601 also satisfied the Morton
(1955) criterion, reaching at . Mul-Z 1 4.0 v  .00max
tipoint linkage analysis (fig. 3) localized the disease in-
terval to a region between markers D4S1582 and
D4S2397, with 3-unit-LOD-score support interval
∼10–22 cM to the right of marker D4S3007.
Haplotype Analysis
Extended haplotypes were constructed on the basis
of the following order of markers: D4S3007–
D4S1582–D4S2639–D4S2944–D4S1602–D4S403–
D4S1601–D4S2397 (fig. 2). These loci represent a re-
gion 12–32 cM from the top of the chromosome. The
presumptive disease-associated haplotype was deter-
mined as a common extended haplotype for all af-
fected individuals. Eight informative recombination
events were identified in the family. On the basis of
these results, the disease interval was localized be-
tween markers D4S1582 and D4S2397 on chromo-
some 4p. Within the region, no recombinations were
detected at loci D4S2639, D4S2944, D4S1602,
D4S403, and D4S1601.
Discussion
STGD was originally described as an autosomal re-
cessive trait (Stargardt 1909). STGD1, a chromosome
1p gene responsible for autosomal recessive STGD, has
recently been cloned (Allikmets et al. 1997b). Autosomal
dominant inheritance of a Stargardt-like phenotype is
less common but has been described in a number of
families (Cibis et al. 1980; Lopez et al. 1990; Mansour
1992; Stone et al. 1994; Zhang et al. 1994). Previous
studies have identified two loci for dominant Stargardt-
like disease: STGD2 and STGD3 (Stone et al. 1994;
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Zhang et al. 1994). In the present study, we have per-
formed genetic-linkage analysis of a kindred affected
with autosomal dominant Stargardt-like disease. A ge-
nomewide search identified a chromosome 4 region con-
taining the disease gene, with several STRmarkers coseg-
regating with the disease phenotype. A two-point Zmax
of 5.12 at was obtained between the disease andv  .00
marker locus D4S403. Multipoint analysis and analysis
of extended haplotypes disclosed recombination events
that restricted the disease interval to an ∼12-cM region
between markers D4S1582 and D4S2397. This defines
a new locus, STGD4, for autosomal dominant Stargardt-
like disease.
A candidate-gene search of a gene map of the human
genome (Deloukas et al. 1998) identified two genes in
this region that are expressed in the retina. The first gene
encodes dihydropyrimidinase-related protein-1 (DRP-1)
and has been mapped by Ge´ne´thon by means of the
radiation-hybrid panel. The biological function of DRP-
1 is unknown, but two homologous proteins, DRP-2 and
DRP-3, are thought to play a role in neuronal growth
and maturation (Hamajima et al. 1996). The second
gene encodes heat-shock protein 90 (HSP90 [MIM
140572]). It has beenmapped by theWhitehead Institute
for Biomedical Research/MIT Center for Genome Re-
search by means of a YAC panel and belongs to a family
of stress-inducible proteins (Rebbe et al. 1989). Heat-
shock proteins are associated with various cellular sig-
naling proteins and are believed to maintain tissue in-
tegrity against thermal, oxidative, and mechanical
stresses. In particular, HSP90 has been shown to be ex-
pressed in rodents during visual-system development
(Kojima et al. 1996).
The study of STGD and other hereditary macular dys-
trophies may have important implications for the study
of AMD, which is the most common cause of irreversible
blindness among elderly individuals in the United States.
Historically, the genetic study of AMD has been limited
by the clinical heterogeneity, late onset, and multifac-
torial etiology of the disease (Heiba et al. 1994; Seddon
et al. 1996, 1997). STGD provides a useful model for
the genetic and molecular study of macular degenera-
tion, because of its numerous phenotypic and histo-
pathological similarities to AMD, including progres-
sively decreased vision, atrophy of the macula and
retinal-pigment epithelium, dysfunction of retinal pho-
toreceptors, and accumulation of debris within the ret-
inal-pigment epithelium (Young 1987). In light of these
similarities, it is reasonable to hypothesize that the ge-
netic basis and pathogenesis of Stargardt-like macular
dystrophy may be related to those of certain subsets of
AMD. Consistent with this hypothesis is a recent report
that certain ABCR sequence changes are found more
commonly in persons with AMD (Allikmets et al. 1997a;
van Driel et al. 1998), although these data remain con-
troversial (Dryja et al. 1998; Klaver et al. 1998; Stone
et al. 1998).
Cloning of the STGD4 gene, as well as further genetic
and molecular study of hereditary macular dystrophies,
should provide important insights into the pathogenesis
of AMD. Compilation and analysis of other genes in-
volved in macular dystrophies and AMDmay eventually
produce a more rational classification system for the
various forms of macular degeneration. Finally, the dis-
covery of specific genetic alterations in macular degen-
eration could create opportunities to improve clinical
diagnosis and to offer more-effective, targeted therapies
for patients.
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